EGFR mutation status in Tunisian non-small-cell lung cancer patients evaluated by mutation-specific immunohistochemistry

BACKGROUND: Screening mutations in epidermal growth factor receptor (EGFR) to analyze non-small-cell lung cancer (NSCLC) profile is the criterion to choose the best therapeutic strategy. New Oncology guidelines recommend EGFR mutation analysis before prescribing tyrosine kinase inhibitors (TKIs) tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Mraihi, Zohra, Ben Amar, Jihen, Bouacha, Hend, Rammeh, Soumaya, Hila, Lamia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085720/
https://www.ncbi.nlm.nih.gov/pubmed/30092812
http://dx.doi.org/10.1186/s12890-018-0706-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085720/
https://www.ncbi.nlm.nih.gov/pubmed/30092812
http://dx.doi.org/10.1186/s12890-018-0706-5

Ejemplares similares